Co-founder @bento_delivered Samurai by marriage via @kyokodole.

Los Angeles, CA
Joined May 2008
“We have to change the ethos of biomedicine to allow failure to happen.” - @NIHDirector_Jay #MIHealthSummit
1
89
There’s a lesson in Figma’s IPO. Per friends, there was a time where Figma did not look like a clear winner. These things can take time. Meanwhile, I see a lot of funds rushing out of healthcare b/c of lack of exits, or b/c AI is hotter. There will be a lot of healthcare Figma’s in the next decade.
8
4
1
96
9,566
People say sales cycles in #Healthcare are really long...& while they often can be, we forget that "healthcare" is not some inanimate object. When a decision maker has an emotional connection to ur mission, turns our sales cycles in healthcare are fast!
87
I’m very excited about what @ReadG & others at @RenPhil21 are building to find new paths forward for #PublicHealth renaissancephilanthropy.org/… #medicaid
2
68
Nothing says spam or laziness more than the "my CEO thought I should reach out to you..." line.
97
Mark Cuban laid into pharmacy benefit managers at the White House today. Three PBMs, middlemen owned by giant healthcare firms like CVS and UnitedHealth, dominate how drugs are priced. And they’re price gouging essential drugs at the expense of patients in need. @mcuban
122
1,085
119
4,307
527,523
This is really bad! People cannot get their medication, doctors cannot submit bills…we need some redundancy in these networks.
This quoted post is unavailable.
2
3
20
4,960
I have no insider insight on whether they can come back. But damn is it refreshing to hear a leader address this so publicly, so unflinchingly, and with the energy and conviction to pull it off shining through.
I still think that to be a real company, you have to be a public company. But I can confirm that losing 94% of your value is as soul-crushing as it seems (not to mention for our investors). I always felt confident that we had all the bones to get the company on track, but when you are plumbing your lowest stock price lows, you wonder: what even are the historical odds that a stock comes back from a 94% peak-to-trough drawdown, like the one OSCR experienced? Here is the answer: in a universe of 3,000 publicly traded companies with a trough valuation of at least $50M, there were 300 companies over the past 10 years that experienced a drawdown of 94% or greater and are still trading. Another 60-80 got delisted. 40 of those ~400 companies (including OSCR) had a rebound since the trough of at least 8x. So that's ~10% odds for such a comeback at the trough. Of those 40 companies, 55% are oil companies, 20% are biotech, and 10% are bitcoin miners. To be clear, we are not even close to done, and have to keep earning our way back up the top. We still have a lot of work to do. But if you can count, then you better never count us out. (GPT-coproduced numbers here if you want to follow along: docs.google.com/spreadsheets…)
2
14
1,963
We've been pretty quiet on social media about a lot of the work we've been up to this past year... but I am excited to start sharing more. Lots of exciting things going on at @textbento.
For the past year, we’ve been partnering w/ @AmDiabetesAssn to improve the lives of our country’s most at-risk community members & are proud to be recognized by them for our approach to improving health outcomes. #FoodIsMedicine #Medicaid
1
2
300
Congratulations @EmilyFPeters & @nickdawson on bringing this vision to life.
1
1
1
5
510
A sad end of an era washingtonpost.com/media/202… – at Malibu, CA
2
119
It's great to see the supreme court sticking up for patients rights and civil liberties. Dignity should not be granted to only those who can afford to pay for it. medpagetoday.com/opinion/the…
83
Am in tears. A mum said her little boy gave her the biggest hug he has ever given her after she told him she set up a funding campaign to get him a Hero Arm. He wanted one so badly but didn't ask for it because he knew they couldn't afford it. The best bit?
1
3
15
1,341
I am still a baffled that investors and even some founders are talking about the importance of revenue, margins and EBITDA like it's a new concept or some next level criteria for building a business worth building.
3
276